DrugCite
Search

MARCAINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Marcaine Adverse Events Reported to the FDA Over Time

How are Marcaine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Marcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Marcaine is flagged as the suspect drug causing the adverse event.

Most Common Marcaine Adverse Events Reported to the FDA

What are the most common Marcaine adverse events reported to the FDA?

Chondrolysis
256 (2.8%)
Musculoskeletal Pain
202 (2.21%)
Anaesthetic Complication
195 (2.13%)
Hypotension
189 (2.07%)
Drug Ineffective
167 (1.83%)
Drug Exposure During Pregnancy
119 (1.3%)
Joint Injury
104 (1.14%)
Pain
100 (1.09%)
Activities Of Daily Living Impaired
98 (1.07%)
Cardiac Arrest
98 (1.07%)
Loss Of Consciousness
86 (.94%)
Show More Show More
Post Procedural Complication
84 (.92%)
Convulsion
76 (.83%)
Bradycardia
73 (.8%)
Hypoaesthesia
69 (.76%)
Asthenia
68 (.74%)
Musculoskeletal Discomfort
67 (.73%)
Musculoskeletal Disorder
67 (.73%)
Headache
66 (.72%)
Nausea
64 (.7%)
Muscular Weakness
61 (.67%)
Vomiting
59 (.65%)
Blood Pressure Decreased
56 (.61%)
Dyspnoea
56 (.61%)
Joint Range Of Motion Decreased
54 (.59%)
Cauda Equina Syndrome
53 (.58%)
Osteoarthritis
53 (.58%)
Arthropathy
49 (.54%)
Dizziness
49 (.54%)
Drug Toxicity
48 (.53%)
Incorrect Route Of Drug Administrat...
44 (.48%)
Oxygen Saturation Decreased
44 (.48%)
Paraplegia
43 (.47%)
Tachycardia
42 (.46%)
Pain In Extremity
41 (.45%)
Death
39 (.43%)
Paraesthesia
39 (.43%)
Anaphylactic Shock
38 (.42%)
Musculoskeletal Stiffness
38 (.42%)
Arthralgia
36 (.39%)
Disseminated Intravascular Coagulat...
36 (.39%)
Procedural Complication
36 (.39%)
Myoclonus
35 (.38%)
Drug Effect Decreased
34 (.37%)
Fall
34 (.37%)
Medication Error
34 (.37%)
Sensory Loss
34 (.37%)
Anaphylactic Reaction
33 (.36%)
Grand Mal Convulsion
33 (.36%)
Respiratory Distress
33 (.36%)
Sensory Disturbance
33 (.36%)
Conjunctival Oedema
32 (.35%)
Hypertension
32 (.35%)
Parophthalmia
32 (.35%)
Pyrexia
32 (.35%)
Respiratory Failure
32 (.35%)
Caesarean Section
31 (.34%)
Movement Disorder
31 (.34%)
Unresponsive To Stimuli
31 (.34%)
Apnoea
30 (.33%)
Erythema
30 (.33%)
Agitation
29 (.32%)
Coma
29 (.32%)
Disorientation
29 (.32%)
Exophthalmos
29 (.32%)
Overdose
29 (.32%)
Respiratory Arrest
29 (.32%)
Hypoxia
27 (.3%)
Synovitis
27 (.3%)
Neuropathy Peripheral
26 (.28%)
Hypersensitivity
25 (.27%)
Pulmonary Oedema
25 (.27%)
Respiratory Depression
25 (.27%)
Somnolence
25 (.27%)
Chondromalacia
24 (.26%)
Drug Hypersensitivity
24 (.26%)
Procedural Hypotension
24 (.26%)
Visual Acuity Reduced
24 (.26%)
Back Pain
23 (.25%)
Circulatory Collapse
23 (.25%)
Confusional State
23 (.25%)
Depressed Level Of Consciousness
23 (.25%)
Drug Interaction
23 (.25%)
Injection Site Pain
23 (.25%)
Insomnia
23 (.25%)
Restlessness
23 (.25%)
Rotator Cuff Syndrome
23 (.25%)
Urinary Incontinence
23 (.25%)
Ventricular Fibrillation
23 (.25%)
Hearing Impaired
22 (.24%)
Heart Rate Increased
22 (.24%)
Spinal Cord Infarction
22 (.24%)
Urinary Retention
22 (.24%)
Pruritus
21 (.23%)
Tremor
21 (.23%)
Abdominal Pain
20 (.22%)
Anxiety
20 (.22%)
Areflexia
20 (.22%)
Catheter Site Related Reaction
20 (.22%)
Diplopia
20 (.22%)
Heart Rate Decreased
20 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Marcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Marcaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Marcaine

What are the most common Marcaine adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Marcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Marcaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Marcaine According to Those Reporting Adverse Events

Why are people taking Marcaine, according to those reporting adverse events to the FDA?

Spinal Anaesthesia
544
Anaesthesia
341
Local Anaesthesia
175
Analgesia
147
Musculoskeletal Pain
143
Epidural Anaesthesia
134
Show More Show More
Pain
107
Nerve Block
78
Drug Use For Unknown Indication
75
Postoperative Analgesia
68
Caesarean Section
63
Procedural Pain
56
Analgesic Effect
53
Product Used For Unknown Indication
50
Analgesic Therapy
44
Pain Management
42
Back Pain
41
Arthralgia
36
Surgery
27
Neuralgia
20
Cancer Pain
19
Knee Arthroplasty
15
Shoulder Operation
15
Anaesthesia Procedure
13
Sedation
12
Labour Pain
11
Post Procedural Pain
10
Arthropathy
10
Nerve Root Compression
10
Cataract Operation
10
Infiltration Anaesthesia
9
Maternal Exposure During Pregnancy
9
General Anaesthesia
9
Joint Dislocation
8
Arthroscopy
8
Appendicectomy
7
Herpes Zoster
7
Cystitis Interstitial
7
Induction Of Anaesthesia
6
Hysterectomy
6
Drug Exposure During Pregnancy
6
Normal Labour
6
Ill-defined Disorder
6
Delivery
5
Spinal Column Stenosis
5
Pain In Extremity
5
Bone Pain
4
Rotator Cuff Syndrome
4
Hypotonia
4
Hip Arthroplasty
4
Anaesthetic Premedication
4

Drug Labels

LabelLabelerEffective
MarcaineGeneral Injectables & Vaccines, Inc24-AUG-10
MarcaineGeneral Injectables & Vaccines, Inc25-APR-11
MarcaineGeneral Injectables & Vaccines, Inc25-APR-11
MarcaineCardinal Health31-JAN-12
Marcaine SpinalHospira, Inc.07-FEB-12
Marcaine With EpinephrineHospira, Inc.08-FEB-12
MarcaineHospira, Inc.08-FEB-12
Marcaine With EpinephrinePhysicians Total Care, Inc.07-MAR-12
MarcainePhysicians Total Care, Inc.07-MAR-12
MarcaineCarestream Health, Inc. 20-APR-12
MarcaineCardinal Health17-APR-13

Marcaine Case Reports

What Marcaine safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Marcaine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Marcaine.